Faeth Therapeutics (FTH) Other Operating Expenses (2020 - 2026)
Faeth Therapeutics' (FTH) quarterly Other Operating Expenses came in at $133.0 million in Q1 2026, up 664685.0% YoY from N/an in Q1 2025, and up 13295800.0% on a QoQ basis from -$1000.0 in Q3 2025.
Faeth Therapeutics (FTH) Other Operating Expenses (2020 - 2026) Analysis & Trends
Faeth Therapeutics (FTH) has 6 years of Other Operating Expenses data on file, last reported at $133.0 million in Q1 2026.
- Quarterly Other Operating Expenses rose 664685.0% year-over-year to $133.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $132.9 million (up 13588.57% YoY) and the FY2024 annual result came in at $951000.0, up 414.9% from the prior year.
- Other Operating Expenses rose to $133.0 million in Q1 2026, from -$1000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $133.0 million in Q1 2026 to a low of -$191000.0 in Q2 2023.
- A 4-year average of $16.7 million and a median of -$3500.0 in 2023 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 664685.0% in 2026, down 664685.0% in 2026.
- Tracing FTH's Other Operating Expenses over 4 years: stood at -$6000.0 in 2023, then jumped by 15950.0% to $951000.0 in 2024, then sank by 100.11% to -$1000.0 in 2025, then jumped by 13295800.0% to $133.0 million in 2026.
- The last three Other Operating Expenses figures came in at $133.0 million (Q1 2026), -$1000.0 (Q3 2025), and -$40000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | Faeth Therapeutics | 176.58 Mn | 176.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 132.96 Mn |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -40,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 951,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Jun 30, 2023 | -191,000.00 |
| Mar 31, 2023 | -105,000.00 |
| Dec 31, 2021 | 19,000.00 |
| Jun 30, 2021 | -28,000.00 |
| Jun 30, 2020 | 738,000.00 |